Skip to main content
PharmAbcine Inc. logo

PharmAbcine Inc. — Investor Relations & Filings

Ticker · 208340 ISIN · KR7208340000 KO Manufacturing
Open in API
Filings indexed 461 across all filing types
Latest filing 2025-03-31 Declaration of Voting R…
Country KR South Korea
Listing KO 208340

About PharmAbcine Inc.

http://pharmabcine.com/

PharmAbcine Inc. is a clinical-stage biotechnology company specializing in the development of fully human therapeutic monoclonal antibodies (mAbs). The company focuses on creating innovative treatments for diseases with high unmet medical needs, primarily in oncology, neovascular eye diseases, and other inflammatory and vascular disorders. Utilizing its proprietary human antibody library and discovery technologies, PharmAbcine advances a pipeline of next-generation IgG-based therapeutics. The company's mission is to contribute to human health by providing novel antibody-based drugs to patients.

Recent filings

Filing Released Lang Actions
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official announcement of the results of a General Meeting of Shareholders (정기주주총회결과). It details the approval of financial statements, dividend resolutions, board appointments, and other agenda items (such as business purpose changes). This falls under the category of Declaration of Voting Results & Voting Rights Announcements.
2025-03-31 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a formal 'Audit Report Submission' (감사보고서 제출) filed by the company 'PharmAbcine' on the Korea Exchange (KRX). It contains the auditor's opinion (unqualified/appropriate), financial statements (consolidated and separate), and key financial metrics such as asset/liability totals, operating losses, and capital impairment ratios. While it provides financial data, it is specifically the regulatory filing of the audit report itself, which falls under the 'Audit Report / Information' category. FY 2024
2025-03-21 Korean
사업보고서 (2024.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) for the 17th fiscal year (2024) for PharmAbcine Inc. It contains detailed company information, financial data, management discussion, and governance details, which is the standard format for an Annual Report in the Korean regulatory context (equivalent to a 10-K). FY 2024
2025-03-21 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for PharmAbcine Inc. It contains the meeting agenda, details on voting procedures, and management information including board activities and business overview. This type of document is a standard proxy statement/notice sent to shareholders to inform them of an upcoming meeting and solicit their participation, which falls under the Proxy Solicitation & Information Statement category.
2025-03-14 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (PharmAbcine) announcing a significant change (over 30%) in revenue or profit structure. This is a standard disclosure requirement in the Korean stock market (KRX) when financial results deviate significantly from the previous period. While it contains financial data, it is an initial announcement of financial performance highlights rather than a full annual report or interim report. Therefore, it is classified as an Earnings Release (ER). FY 2024
2025-03-14 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) issued by PharmAbcine. It outlines the date, location, and agenda items (such as financial statement approval, articles of incorporation changes, and director compensation limits) for the upcoming Annual General Meeting. This type of document is a standard proxy solicitation or notice of meeting material provided to shareholders to inform them of the meeting and request their participation/votes.
2025-03-14 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.